Mashal Akhter, MD
Retina Specialist · Columbus, OHNPI 1669853743
Payments from drug & device makers
What this record shows
This record is dominated by grants: $98,001 of the $102,309 with a category attached, or 95.8%. Regeneron accounts for 95.8% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2020 at $50,523 and has fallen 98.9% since, to $534 in 2025. Among retina specialist clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 138 payments — averaging $741.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron$98K
- Regeneron Healthcare Solutions, Inc.$1K
- Novartis$628
- Genentech USA, Inc.$620
- Alimera Sciences, Inc.$347
- Apellis Pharmaceuticals, Inc.$320
- plus $982 from 9 others
What the payments were for
- Grants$98,00196%
- Food & beverage$4,3084%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron | 13 | $98,001 |
| Regeneron Healthcare Solutions, Inc. | 42 | $1,412 |
| Novartis | 6 | $628 |
| Genentech USA, Inc. | 28 | $620 |
| Alimera Sciences, Inc. | 8 | $347 |
| Apellis Pharmaceuticals, Inc. | 14 | $320 |
| Astellas Pharma US Inc | 7 | $213 |
| AbbVie | 8 | $178 |
| Alcon | 3 | $142 |
| Mallinckrodt Enterprises LLC | 2 | $136 |
| Shire North American Group Inc | 1 | $115 |
| Eyepoint US, Inc. | 1 | $110 |
| Bausch & Lomb Americas Inc. | 3 | $45 |
| ANI Pharmaceuticals, Inc. | 1 | $30 |
| Spark Therapeutics, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$102,309 in reported general payments places this provider in the 90th percentile of 69 retina specialist providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 214 | $5,579 |
| Atropine Sulfate | 94 | $3,397 |
| Difluprednate | 33 | $2,967 |
| Ketorolac Tromethamine | 44 | $905 |
| Brimonidine Tartrate | 31 | $487 |
| Ciprofloxacin Hcl | 53 | $482 |
| ErythromycinErythromycin Base | 36 | $378 |
| Ofloxacin | 39 | $365 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 31 | $316 |
| Latanoprost | 13 | $48 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in Columbus
- Christiane HuntColumbus$4K
- Matthew ByunColumbus$4K
- Harrison SciulliColumbus$4K
- Chirag PatelColumbus$3K
- Reece BergstromColumbus$2K
- Fatoumata YanogaColumbus$585
- Matthew OhrColumbus$316
- Ana Suelves CogollosColumbus$288
- Joseph ConeyBeachwood$980K
- Sumit SharmaCleveland$428K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.